Schroder Investment Management Group
BEAM icon

Schroder Investment Management Group’s Beam Therapeutics BEAM Stock Holding History

Schroder Investment Management Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,500
Closed -$522K – 1167
2025
Q1 		$522K Hold
23,500
– – ﹤0.01% 1075
2024
Q4 		$594K Hold
23,500
– – ﹤0.01% 1081
2024
Q3 		$589K Hold
23,500
– – ﹤0.01% 1092
2024
Q2 		$551K Hold
23,500
– – ﹤0.01% 1094
2024
Q1 		$776K Hold
23,500
– – ﹤0.01% 1059
2023
Q4 		$640K Sell
23,500
-40,522
-63% -$1.01M ﹤0.01% 1061
2023
Q3 		$1.54M Sell
64,022
-92,383
-59% -$2.48M ﹤0.01% 949
2023
Q2 		$4.99M Sell
156,405
-102,538
-40% -$3.33M 0.01% 789
2023
Q1 		$7.93M Buy
258,943
+45,156
+21% +$1.78M 0.01% 686
2022
Q4 		$8.36M Buy
213,787
+3,145
+1% +$141K 0.01% 670
2022
Q3 		$10M Sell
210,642
-67,862
-24% -$3.87M 0.02% 610
2022
Q2 		$11.3M Buy
+278,504
New +$11.1M 0.02% 624

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Schroder Investment Management Group's BEAM Position: Q2 2025 in Review

Schroder Investment Management Group sold out of Beam Therapeutics (BEAM) in Q2 2025, closing a stake of 23,500 shares — an estimated $522K sold.

Schroder Investment Management Group first reported a position in BEAM in Q2 2022 and held it in 12 quarters. The position peaked at $11.3M in Q2 2022. 217 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.

  • Schroder Investment Management Group reported no remaining Beam Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 23,500 Beam Therapeutics shares in Q2 2025, an estimated $522K.
  • Schroder Investment Management Group first reported a position in Beam Therapeutics in Q2 2022 and held it in 12 quarters.
  • Schroder Investment Management Group's Beam Therapeutics position peaked at $11.3M in Q2 2022.
  • 217 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.

Based on Schroder Investment Management Group's 13F filing for Q2 2025, filed 13 Aug 2025.